Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today.
Revenues increased 31% year-over-year to $17.7 billion.
Net income was $4.46 billion, or $0.78 per share, compared to a loss of $2.38 billion, or $0.42 per share, last year. Adjusted EPS amounted to $1.06.
For the full year of 2024, Pfizer expects revenues of $61-64 billion and adjusted EPS of $2.75-2.95.
(This story will be updated shortly with an infographic)
The post PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
